The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase. 2006

B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001215 Asparaginase A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1. Asparaginase II,Asparaginase medac,Asparagine Deaminase,Colaspase,Crasnitin,Elspar,Erwinase,Kidrolase,Leunase,Paronal,Deaminase, Asparagine,medac, Asparaginase
D001217 Aspartate-Ammonia Ligase An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1. Asparagine Synthase,Asparagine Synthetase,Asparagine Synthetase B,Aspartate Ammonia Ligase,Ligase, Aspartate-Ammonia,Synthase, Asparagine,Synthetase B, Asparagine,Synthetase, Asparagine
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D034622 RNA Interference A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process. Gene Silencing, Post-Transcriptional,Post-Transcriptional Gene Silencing,Co-Suppression,Cosuppression,Posttranscriptional Gene Silencing,RNA Silencing,RNAi,Co Suppression,Gene Silencing, Post Transcriptional,Gene Silencing, Posttranscriptional,Gene Silencings, Posttranscriptional,Interference, RNA,Post Transcriptional Gene Silencing,Post-Transcriptional Gene Silencings,Silencing, Post-Transcriptional Gene

Related Publications

B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
April 1989, Leukemia,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
August 2012, Experimental hematology,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
October 2012, Bioorganic & medicinal chemistry,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
February 1979, Biochemical Society transactions,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
April 2003, Blood,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
October 1969, Biochemical pharmacology,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
August 1977, Biochemical pharmacology,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
April 2009, Anticancer research,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
July 2001, The Biochemical journal,
B S Li, and L J Gu, and C Y Luo, and W S Li, and L M Jiang, and S H Shen, and H Jiang, and S H Shen, and B Zhang, and J Chen, and H L Xue, and J Y Tang
April 1968, Biochemical and biophysical research communications,
Copied contents to your clipboard!